Blood collection tube, method for preparing decellularized plasma and application

By setting up an inner tube for filtering cell functions in the blood collection tube, the simplified preparation of decellularized plasma is achieved, and the high requirements and complex operation of equipment in the existing technology is solved, the cost and contamination risk is reduced, and it is suitable for routine hospitals and physical examinations. center.

CN119055236APending Publication Date: 2024-12-03SHANGHAI WEIHE MEDICAL LAB CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411171036.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The prior art has problems such as high equipment requirements, complex operation, high pollution risk and high cost in the preparation of decellularized plasma, especially in conventional hospitals and physical examination centers, which are difficult to achieve effective decellularized plasma collection and preparation.

Method used

A blood collection tube including an inner tube with filtered cell function is provided, and plasma is filtered in the outer tube by a low-speed centrifugation operation, blocking cells and cell debris, simplifying the preparation process of decellularized plasma and reducing equipment and labor costs.

Benefits of technology

It realizes simple and efficient preparation of decellularized plasma, reduces the risk of contamination, expands the application scenarios of decellularized plasma preparation, is suitable for routine hospitals and physical examination centers, and reduces time, material and labor costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055236A_ABST
    Figure CN119055236A_ABST
Patent Text Reader

Abstract

The embodiment of the invention relates to a blood collection tube, a method for preparing decellularized plasma and application. The blood collection tube comprises: an outer tube (110) comprising an outer tube wall (230) extending in a first direction (A); the inner tube (120) is fixed in the outer tube (210) and comprises an inner tube wall (330) extending in the first direction (A), the inner tube wall (330) comprises a filtering part (340) and a containing part (331), the containing part (331) is located between the filtering part (340) and an inner tube bottom (310) of the inner tube (120), the filtering part (340) is separated from the outer tube wall (230), and the filtering part (340) comprises a plurality of filtering holes (341) used for filtering cells. In this way, a tedious two-step centrifugation method in a conventional decellularized plasma collection and preparation method is simplified, and the decellularized plasma can be obtained through one-time centrifugation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of clinical medical devices, and in particular to a method for collecting and preparing decellularized plasma, and the use of the blood collection tube in preparing decellularized plasma. Background Art

[0002] Circulating free DNA (cell-free DNA, cfDNA) is a degraded DNA molecule with a length of 50-300 base pairs released by cells into the blood. cfDNA usually exists in low concentrations in the blood of healthy people, but it is of great significance in disease detection (such as tumor detection and monitoring). However, cells and organelles contain a large amount of DNA, and the content of these DNAs is much higher than cfDNA. In order to avoid cfDNA being contaminated by DNA in cells and organelles, cell-free plasma (Cell-Free Plasma) needs to be prepared first. Summary of the invention

[0003] In a first aspect of the present disclosure, a blood collection tube is provided. The blood collection tube comprises: an outer tube, comprising an outer tube wall extending in a first direction; an inner tube, fixed in the outer tube and comprising an inner tube wall extending in the first direction, wherein the inner tube wall comprises a filter portion and a receiving portion, wherein the receiving portion is located between the filter portion and the inner tube bottom of the inner tube, the filter portion is spaced apart from the outer tube wall, and the filter portion comprises a plurality of filter holes for filtering cells

[0004] In a second aspect of the present disclosure, a method for preparing decellularized plasma is provided, comprising: placing whole blood of a subject in an inner tube of a blood collection tube according to any one of the preceding claims; performing a centrifugal operation on the blood collection tube so that plasma in the whole blood passes through a filtering portion of the inner tube and enters an outer tube of the blood collection tube; removing the inner tube from the blood collection tube; and obtaining the plasma in the outer tube.

[0005] In the third aspect of the present disclosure, a use is provided, which is the use of the blood collection tube according to the first aspect of the present disclosure in preparing decellularized plasma.

[0006] It should be understood that the contents described in the summary of the invention are not intended to limit the key or important features of the embodiments of the present disclosure, nor are they intended to limit the scope of the present disclosure. Other features of the present disclosure will become easily understood through the following description. BRIEF DESCRIPTION OF THE DRAWINGS

[0007] In order to better understand the above and other purposes, features, advantages and functions of the present disclosure, reference may be made to the preferred embodiments shown in the accompanying drawings. The same reference numerals in the accompanying drawings refer to the same components. It should be understood by those skilled in the art that the accompanying drawings are intended to schematically illustrate the preferred embodiments of the present disclosure and have no limiting effect on the scope of the present disclosure, and the components in the drawings are not drawn to scale.

[0008] Figure 1 A schematic diagram of an example blood collection tube according to an embodiment of the present disclosure is shown;

[0009] Figure 2 A schematic diagram showing an outer tube of an exemplary blood collection tube according to an embodiment of the present disclosure is shown;

[0010] Figure 3 A schematic diagram of an inner tube of an exemplary blood collection tube according to an embodiment of the present disclosure is shown;

[0011] Figure 4 A schematic diagram of a tube cover of an exemplary blood collection tube according to an embodiment of the present disclosure is shown;

[0012] Figure 5 A schematic diagram of a filter membrane of an exemplary blood collection tube according to an embodiment of the present disclosure is shown;

[0013] Figure 6 A flow chart showing an exemplary method for preparing decellularized plasma according to an embodiment of the present disclosure is shown;

[0014] Figures 7A-7C A schematic diagram showing various exemplary states in a process of preparing decellularized plasma according to an embodiment of the present disclosure; and

[0015] Figure 8 Schematic diagram showing the distribution of cfDNA fragments extracted from decellularized plasma obtained using blood collection tubes and different preparation methods. DETAILED DESCRIPTION

[0016] Various embodiments are now described with reference to the accompanying drawings, wherein throughout the text, similar reference numerals are used to refer to similar elements. In the following description, for the purpose of explanation, many specific details are set forth to facilitate a thorough understanding of one or more embodiments. However, it may be clear in some or all cases that any embodiment described below can be practiced without adopting the specific design details described below. In other examples, known structures and devices are shown in block diagram form to facilitate description of one or more embodiments. A simplified overview of one or more embodiments is given below to provide a basic understanding of the embodiments. This overview is not an exhaustive overview of all contemplated embodiments, is not intended to identify the key or important elements of all embodiments, and is not intended to define the scope of any or all embodiments.

[0017] References to "an embodiment" or "one embodiment" in the framework of this description are intended to indicate that a particular configuration, structure, or characteristic described with respect to the embodiment is included in at least one embodiment. Thus, phrases such as "in an embodiment" or "in an embodiment" that may be present in one or more points of this description do not necessarily refer to the same embodiment. Furthermore, in one or more embodiments, particular configurations, structures, or characteristics may be combined in any appropriate manner.

[0018] In the following disclosure, unless otherwise indicated, when referring to absolute position modifiers (such as terms "front", "back", "top", "bottom", "left", "right", etc.) or relative position modifiers (such as terms "above", "below", "higher", "lower", etc.), or when referring to directional modifiers (such as "horizontal", "vertical", etc.), it refers to the orientation shown in the figure.

[0019] As discussed above, there is a need for preparing cell-free plasma in the related art. In the related art, the method for preparing cell-free plasma is usually a two-step centrifugation method, that is, firstly removing cells by low-speed centrifugation (about 3000g), and then taking the supernatant for high-speed centrifugation (12000-16000g) to remove cell debris.

[0020] However, high-speed centrifugation usually needs to be operated by professionals using specific equipment, and most conventional hospitals or physical examination centers may not be equipped with centrifuges that can perform high-speed centrifugation at 12,000-16,000 g. In this case, the whole blood needs to be transported to a specialized institution for processing, but the transportation process can easily cause the white blood cells in the blood to rupture and release a large amount of gDNA, causing cfDNA contamination. In addition, devices used to transport whole blood at room temperature, such as sampling tubes with preservatives, include a variety of other components that may cause cfDNA contamination, such as preservatives, in addition to common anticoagulants, and are relatively expensive.

[0021] In addition, in the related art, ultrafiltration tubes can also be used to prepare decellularized plasma. However, such methods also have some problems. For example, the cell membrane is relatively fragile, and it may rupture by shearing with the pores of the filter membrane during centrifugation, resulting in gDNA contamination and clogging of the filter membrane. Secondly, ultrafiltration tubes are generally single-layer filter membranes, which cannot effectively separate cells and organelles of different sizes.

[0022] In view of this, the embodiments of the present disclosure propose a simpler and lower-cost solution for collecting and preparing decellularized plasma. In this solution, a blood collection tube including an inner tube with a cell filtering function is provided. The blood collection tube includes an outer tube and an inner tube located inside the outer tube, and a filter portion for filtering cells is provided on the tube wall of the inner tube, so that the interior of the inner tube is connected to the interior of the outer tube. Therefore, when the blood collection tube is centrifuged, the filter portion allows the plasma in the inner tube to pass through and enter the outer tube, while blocking cells and fragments and organelles after cell fragmentation.

[0023] Compared with the scheme of decellularized plasma in the related art, the scheme of decellularized plasma according to the present disclosure simplifies the cumbersome two-step centrifugation method in the conventional decellularized plasma collection and preparation method, and the decellularized plasma can be obtained by a single centrifugation. In addition, when the blood collection tube according to the present disclosure is used to collect and prepare decellularized plasma, the decellularized plasma can be obtained by low-speed centrifugation, which reduces the high requirements for equipment (such as high-speed centrifuges) in the conventional decellularized plasma preparation method. As a result, the time cost, labor cost, material cost and other costs are reduced. Due to the simplification of the steps, the scheme according to the present disclosure is easy to operate and reduces the pollution that may occur during the preparation of decellularized plasma. At the same time, the scheme according to the present disclosure expands the application scenarios of the decellularized plasma preparation device, and the blood collection tube according to the present disclosure can be used in physical examination centers and conventional hospitals to achieve the preparation of decellularized plasma, and it is conducive to integrated automation.

[0024] The following will be combined Figures 1 to 8 The blood collection tube and the method for preparing decellularized plasma according to the present disclosure are described in detail. Figure 1 FIG. 1 is a schematic diagram of an exemplary blood collection tube 100 according to an embodiment of the present disclosure. Figure 1 As shown, the blood collection tube 100 includes an outer tube 110 for containing plasma from which cells have been removed by centrifugation. An inner tube 120 for containing whole blood before centrifugation and containing cells after centrifugation is fixed in the outer tube 110. The blood collection tube 100 also includes a tube cap 130 for sealing the inner tube 120 in the outer tube 110. Figures 2 to 5 The structures of the outer tube 110 , the inner tube 120 and the tube cover 130 are described respectively.

[0025] Figure 2 FIG. 1 is a schematic diagram of an outer tube 110 of an exemplary blood collection tube according to an embodiment of the present disclosure. Figure 2 As shown, the outer tube 110 includes a circular outer tube bottom 210 at one end. The other end of the outer tube 110 includes an outer tube mouth 120. The outer tube 110 also includes an outer tube wall 230 extending from the outer tube bottom 210 to the outer tube mouth 220 along a first direction A pointing from the outer tube bottom 210 to the outer tube mouth 220. The outer tube wall 230 has a circular cross section.

[0026] In the illustrated embodiment, the outer tube mouth 220 is used to cooperate with the cap 130 to achieve sealing on the one hand, and to fix the inner tube 120 on the other hand. In this regard, the outer tube mouth 220 includes an outer tube flange 221 extending outward from the outer tube wall 230, that is, radially in a direction away from the outer tube wall 230. The outer tube flange 221 forms a ring around the outer tube wall 230. The outer tube flange 221 includes a second inner surface facing the outer tube bottom 210, and a second outer surface 222 facing away from the outer tube bottom 210. The second outer surface 222 is used to support the inner tube 120. In addition, the outer tube mouth 220 also includes an outer tube mouth peripheral wall 223 extending from the outer edge of the outer tube flange 221 in a first direction. The inner surface of the outer tube mouth peripheral wall 223 can be tightly abutted against the tube cover 130 to achieve sealing of the inner part of the outer tube 110. It should be understood that the method for fixing the inner tube 120 defined in the embodiment of the present disclosure is only exemplary. For example, a bracket may be disposed inside the outer tube, so that the inner tube is fixed on the bracket. The present disclosure is not intended to be limited in this regard.

[0027] Figure 3 FIG. 1 is a schematic diagram of an inner tube 120 of an exemplary blood collection tube according to an embodiment of the present disclosure. Figure 3 As shown, the inner tube 120 includes a circular inner tube bottom 310 at one end. The other end of the inner tube 120 includes an inner tube mouth 320. The inner tube 120 also includes an inner tube wall 330 extending from the inner tube bottom 310 to the inner tube mouth 320 along a first direction A. The inner tube wall 330 has a circular cross-section. In the illustrated embodiment, the inner tube mouth 320 of the inner tube 120 includes an inner tube flange 321 extending outward from the inner tube wall 330. The inner tube flange 321 includes a first inner surface 322 facing the inner tube bottom 310 and a first outer surface facing away from the inner tube bottom 310. The outer diameter of the inner tube flange 321 is greater than the inner diameter of the outer tube 110, so that the inner tube 120 can be fixed on the outer tube 110 by bridging the first outer surface on the second outer surface 222 of the outer tube flange 221. In addition, the outer diameter of the inner tube 120 is smaller than the inner diameter of the outer tube 110, and the length of the inner tube 120 is smaller than the length of the outer tube 110, so that after the inner tube 120 is fixed to the outer tube 110, the inner tube bottom 310 is spaced apart from the outer tube bottom 210, and the inner tube wall 330 is spaced apart from the outer tube wall 230. It should be understood that the positional relationship in which the inner tube bottom 310 is spaced apart from the outer tube bottom 210 in this embodiment is only exemplary, and the inner tube bottom 310 may be in partial contact with the outer tube bottom 210.

[0028] In the illustrated embodiment, the inner tube wall 330 further includes a filter portion 340 adjacent to the inner tube port 320 in the first direction A and a receiving portion 331 adjacent to the inner tube bottom 310, so that the receiving portion 331 is located between the filter portion 340 and the inner tube bottom 310. The filter portion 340 includes a plurality of filter holes 341 for filtering cells (such as broken cell fragments and organelles), and the receiving portion 331 does not include holes, so that the cells blocked in the inner tube 120 by the filter portion 340, that is, cell precipitation and broken cell fragments and organelles can be accommodated. Since after the inner tube 120 is fixed on the outer tube 110, the inner tube bottom 310 is spaced apart from the outer tube bottom 210, and the inner tube wall 330 is spaced apart from the outer tube wall 230, the filter portion 340 on the inner tube wall 330 allows the interior of the inner tube 120 to communicate with the interior of the outer tube 110, so that the liquid in the inner tube 120 can enter the outer tube 110 from the inner tube 120 through the filter portion 340. In an embodiment for filtering cells, the average pore size of the plurality of filter holes 341 is in the range of 0.1 μm-1.5 μm. In some embodiments, the pore size of the filter holes 341 may be in the range of 0.2 μm-0.8 μm. In some embodiments, the ratio between the distance from the bottom of the filter portion 340 to the bottom of the inner tube 310 and the length of the inner tube wall 230 may be at least 45%. In some embodiments, the above ratio may also be 45%-70%, 45%-65%, 45%-60%, 45%-55%, 45%-50% or 45%.

[0029] In some embodiments, the filter unit 340 includes at least one opening opened on the inner tube wall 330, and a filter membrane 343 laid on the inner tube wall 330 and covering the at least one opening. The filter membrane 343 includes a plurality of filter holes 341. Figure 3 In the embodiment of the present invention, the inner tube wall 330 includes at least three openings, namely, opening 342-1, opening 342-2 and opening 342-3. A filter membrane 343 is laid on the inner wall of the inner tube wall 330. The filter membrane 343 covers the openings 342-1, opening 342-2 and opening 342-3 in the inner tube wall 330.

[0030] In some embodiments, the filter membrane 343 may be a multi-layer porous membrane. For example, the filter membrane 343 may be a double-layer porous membrane. Figure 5 The filter membrane 343 implemented as a double-sided porous membrane will be described. Figure 5 FIG. 3 is a schematic diagram of a filter membrane 343 of an exemplary blood collection tube according to an embodiment of the present disclosure. Figure 5 Only the filter membrane is shown without showing other components. Figure 5As shown, the double-layer filter membrane includes a first filter membrane 510 and a second filter membrane 520. The first filter membrane 510 and the second filter membrane 520 are stacked together when unfolded to form a double-layer filter membrane 343. When laid on the inner tube wall 330 of the inner tube 120, the first filter membrane 510 is located inside the second filter membrane 520, that is, farther away from the inner tube wall 330 than the second filter membrane 520.

[0031] Here, the first filter membrane 510 includes a plurality of first filter holes 511 among the plurality of filter holes 341. The second filter membrane 520 includes a plurality of second filter holes 521 among the plurality of filter holes 341. The first filter aperture of the first filter aperture 511 is larger than the second filter aperture of the plurality of second filter apertures 521. In some embodiments, the first filter aperture may be in the range of 0.5 μm-1.5 μm, and the second filter aperture may be in the range of 0.1 μm-0.5 μm. In other embodiments, the first filter aperture may be in the range of 0.5 μm-0.8 μm and the second filter aperture may be in the range of 0.2 μm-0.5 μm. In such an embodiment, by providing a multilayer filter membrane with different apertures, the filtering effect can be improved to prevent excessive impurities from entering the outer tube.

[0032] Figure 4 FIG. 1 is a schematic diagram of a tube cap 130 of an exemplary blood collection tube according to an embodiment of the present disclosure. Figure 4 As shown, the tube cover 130 includes a circular cover body 410. An annular wall 420 extending from a first end face 411 in a direction away from the first end face 411 is formed on the outer periphery of the cover body 410. In addition, a column 430 extending from the second end face 412 in a direction away from the second end face 412 is formed on the second end face 412 of the cover body 410 opposite to the first end face 411. The inner wall of the annular wall 420 is spaced from the outer wall of the column 430 to form a space between the annular wall 420 and the column 430 for accommodating the outer tube mouth peripheral wall 223 of the outer tube 110. The cover body 410 also includes a first recessed portion extending downward from the first end face 411 formed in the middle. At the same time, the column 430 is hollow, so that the thickness of the center of the tube cover 130 is small, which is conducive to the insertion of the needle tube. In some embodiments, the tube cover 130 can be made of an elastic material.

[0033] The structures of the different components of the blood collection tube 100 have been described in detail so far. Figure 1 In some embodiments, when assembling the blood collection tube 100, the Figure 2 The outer tube 120 in the embodiment shown is then Figure 3The inner tube flange 321 of the inner tube 120 is placed on the outer tube flange 221 of the outer tube mouth 220, so that the inner tube 120 is fixed on the outer tube 110. After the inner tube 120 is placed, a reagent 140 suitable for performing acellular plasma preparation, such as an anticoagulant, is added to the inner tube 120. Finally, a negative pressure is formed in the tube and the tube cover 130 is covered on the outer tube mouth 320. The inner tube flange 321 is pressed against the outer tube flange 221 by the end of the column 430 of the tube cover 130, and the column 430 and the annular wall 420 are clamped on the outer tube mouth peripheral wall 223, so that the space inside the tube is sealed. In this way, a blood collection tube 100 in a state that can be sold on the market is obtained.

[0034] In some embodiments, after the user gets the blood collection tube 100, the user can insert one end of the needle tube for blood collection into the blood collection tube 100 and the other end into the blood vessel of the subject. At this time, since the blood collection tube 100 is under negative pressure, the whole blood of the subject flows into the inner tube 120 of the blood collection tube 100 under the action of the pressure difference. Afterwards, the user can use the blood collection tube 100 with the whole blood of the subject to prepare acellular plasma. Figures 6 to 7C To describe the preparation of cell-depleted plasma.

[0035] Figure 6 FIG. 6 is a flow chart showing an exemplary method 600 for preparing decellularized plasma according to an embodiment of the present disclosure. Figure 6 As shown, at 602, Figure 1 The whole blood of the subject is placed in the inner tube 120 of the blood collection tube 100 in the embodiment shown. In some embodiments, the whole blood can be collected from the subject using the blood collection tube under negative pressure. For example, after a channel is formed between the subject's blood vessel and the blood collection tube, the whole blood can flow from the blood vessel into the inner tube 120 of the blood collection tube 100 through the tube cap 130 under the action of the pressure difference. At this time, the state in the blood collection tube 100 is as follows: Fig. 7A As shown. Fig. 7A As shown, the inner tube 120 of the blood collection tube 100 is fixed in the outer tube 110 via the tube cap 130. At this time, the inner tube 120 contains whole blood 710.

[0036] At 604, the blood collection tube 100 is centrifuged so that the plasma in the whole blood passes through the filter portion 340 of the inner tube 120 and enters the outer tube 110 of the blood collection tube 100. In some embodiments, after the whole blood 710 and the anticoagulant 140 in the inner tube 120 are evenly mixed, the obtained blood collection tube 100 containing the whole blood 710 is placed in a centrifuge and centrifuged under appropriate centrifugal conditions. Under the action of centrifugal force, the cells in the whole blood 710 are precipitated to the bottom 310 of the inner tube to form a cell precipitate 711, and under the action of centrifugal force, the upper plasma is filtered through the filter membrane 343 covering the opening on the inner tube wall 330 of the inner tube 120 near the inner tube mouth 320 to remove cell debris and organelles. The cell debris and organelles are retained in the inner tube 120, while the plasma flows into the outer tube 110, thereby obtaining decellularized plasma 712. Figure 7B As shown, the inner tube 120 of the blood collection tube 100 contains cell sediment 711 , while the outer tube 110 contains cell-free plasma 712 .

[0037] In some embodiments, the centrifugation operation is a low-speed centrifugation operation. The conditions of the low-speed centrifugation operation can be: the centrifugal force is 1500-4500g, the centrifugation time is 5-20 minutes, and the centrifugation temperature is 2-8°C. In some embodiments, the conditions of the low-speed centrifugation operation can be: the centrifugal force is 2000-3000g, the centrifugation time is 10-15 minutes, and the centrifugation temperature is 2-8°C.

[0038] At 606, the inner tube 120 is removed from the blood collection tube 100, and at 608, the plasma in the outer tube 110 is obtained. In some embodiments, the tube cap 130 can be opened, the inner tube 120 can be removed and discarded, and the outer tube 110 can be closed again with the tube cap 130 to obtain the decellularized plasma 711 placed inside the outer tube 110. Figure 7C As shown, the inner tube 120 of the blood collection tube 100 is taken out, and the tube cap 130 is fixed on the outer tube 110 to seal the cell-free plasma 711 in the outer tube 110 .

[0039] Figure 8 A schematic diagram of the distribution of cfDNA fragments extracted from decellularized plasma obtained using blood collection tubes and different preparation methods is shown. Here, whole blood was collected from the same source using Streck blood collection tubes, blood collection tubes according to embodiments of the present disclosure, and EDTA blood collection tubes with ethylenediaminetetraacetic acid (EDTA) anticoagulant coated on the inner wall commonly used in the art, and divided into 4 groups, wherein 1 tube of whole blood was collected using blood collection tubes according to embodiments of the present disclosure (experimental group 1) and Streck blood collection tubes (experimental group 3), and 2 tubes of whole blood were collected using EDTA blood collection tubes (control group and experimental group 2). Plasma separation was performed on the 4 groups of whole blood as follows:

[0040] Control group: Whole blood collected with EDTA was used to prepare cell-free plasma by two-step centrifugation according to the commonly used method in the art. The specific steps are as follows:

[0041] 1. Collect whole blood using EDTA blood collection tubes and centrifuge at 3000g for 10 minutes at 4°C;

[0042] 2. Move the upper plasma layer to a new centrifuge tube, being careful not to suck up the buffy coat layer containing white blood cells and the lower red blood cells;

[0043] 3. Centrifuge the centrifuge tube containing plasma at 16000g for 10 minutes at 4°C;

[0044] 4. Save the upper plasma into a new test tube to obtain cell-free plasma.

[0045] Experimental Group 1: Whole blood collected by the blood collection tube according to the present disclosure was used, and the cell-free plasma was prepared by a one-step centrifugation method according to the method for collecting and preparing cell-free plasma described in the present disclosure. The specific steps are as follows:

[0046] 1. Collect whole blood using the blood collection tube according to the present disclosure and mix well;

[0047] 2. Centrifuge at 3000 g for 10 minutes at 4°C.

[0048] 3. Take out and discard the tube rack (200), and seal the tube body (400) with the tube cap (100) to obtain the cell-free plasma placed inside the tube body (400).

[0049] The filter membrane used in the blood collection tube used in this embodiment is a double-layer filter membrane made of polyethersulfone, the average pore size of the inner filter membrane is about 0.8 μm, and the average pore size of the outer filter membrane is about 0.4 μm.

[0050] Experimental Group 2: Whole blood collected using EDTA blood collection tubes was subjected to the one-step centrifugation method in Experimental Group 1 to prepare cell-free plasma. The specific steps are as follows:

[0051] 1. Collect whole blood using EDTA blood collection tubes and centrifuge at 3000 g for 10 minutes at 4°C;

[0052] 2. Transfer the upper plasma to a new centrifuge tube, being careful not to aspirate the buffy coat layer containing white blood cells and the lower red blood cells, to obtain decellularized plasma.

[0053] Experimental group 3: Using whole blood stored in Streck blood collection tubes, acellular plasma was prepared according to the method of experimental group 2. The specific steps are as follows:

[0054] 1. Centrifuge whole blood stored in Streck blood collection tubes at 3000 g for 10 minutes at 4°C;

[0055] 2. Transfer the upper plasma to a new centrifuge tube, being careful not to aspirate the buffy coat layer containing white blood cells and the lower red blood cells, to obtain decellularized plasma.

[0056] The cell-free plasma collected from the control group and experimental groups 1, 2, and 3 was used to extract cfDNA using the QIAamp Circulating Nucleic Acid Kit (50), and the fragment size of the extracted cfDNA was analyzed using labchip.

[0057] Theoretically, the main peak of cfDNA is around 166bp, and the second peak is around 332bp. There should be no obvious peak in the longer fragment region. If there is a peak in the longer fragment region, such as the region above 500bp, it means that the cfDNA is contaminated by large fragment DNA in cells or organelles, such as gDNA.

[0058] After extraction, the results are as follows Figure 8 As shown: Experimental group 1 (according to the blood collection tube disclosed in the present invention) was separated by one-step centrifugation and then the cell-free plasma was extracted to obtain cfDNA. The fragment distribution of cfDNA was consistent with that of the control group, specifically: the main peak position was consistent, both around 166 bp; there were two peaks, and there was no large fragment DNA contamination of more than 500 bp. Experimental groups 2 and 3 were contaminated with large fragment DNA of more than 500 bp after only one-step centrifugation.

[0059] Therefore, the blood collection tube and the method of using the blood collection tube for collecting and preparing cell-free plasma proposed in the present disclosure do not need to undergo a cumbersome two-step centrifugation, and the pretreatment of cfDNA plasma can be completed in one centrifugation, and the centrifugal separation of plasma and blood cells, as well as the separation of organelles and cell fragments in plasma can be completed at the same time. Moreover, according to the scheme of the present disclosure, high-speed centrifugation of 12000-16000g is not required, and the pretreatment of cfDNA plasma can be completed only by low-speed centrifugation.

[0060] The embodiments of the present disclosure have been described above, and the above description is exemplary, not exhaustive, and is not limited to the disclosed embodiments. Many modifications and changes will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments. The selection of terms used herein is intended to best explain the principles of the embodiments, practical applications, or improvements to the technology in the market, or to enable other persons of ordinary skill in the art to understand the various implementations disclosed herein.

Claims

1. A blood collection tube (100), comprising: An outer tube (110) comprising an outer tube wall (230) extending along a first direction (A); an inner tube (120) fixed in the outer tube (210) and comprising an inner tube wall (330) extending along the first direction (A), The inner tube wall (330) includes a filtering portion (340) and a receiving portion (331), wherein the receiving portion (331) is located between the filtering portion (340) and the inner tube bottom (310) of the inner tube (120), the filtering portion (340) is spaced apart from the outer tube wall (230), and the filtering portion (340) includes a plurality of filtering holes (341) for filtering cells.

2. The blood collection tube (100) according to claim 1, wherein the pore size of the filter hole (341) is in the range of 0.1 μm-1.5 μm.

3. The blood collection tube (100) according to claim 2, wherein the pore size of the filter hole (341) is in the range of 0.2 μm-0.8 μm.

4. The blood collection tube (100) according to claim 1, wherein the filter portion (340) comprises: At least one opening (342-1, 342-2, 342-3) is provided on the inner tube wall (330); as well as A filter membrane (343) is laid on the inner tube wall (330) and covers the at least one opening (342-1, 342-2, 342-3).

5. The blood collection tube (100) according to claim 4, wherein the filter membrane (343) comprises: A first filter membrane (510), comprising a plurality of first filter holes (511) among the plurality of filter holes (341), wherein the first filter holes (511) have a first filter pore size; as well as The second filter membrane (520) comprises a plurality of second filter holes (521) among the plurality of filter holes (341), wherein the plurality of second filter holes (521) have a second filter pore size, The first filter membrane (510) is located inside the second filter membrane (520), and the first filter pore size is larger than the second filter pore size.

6. The blood collection tube (100) according to claim 5, wherein the first filter pore size is in the range of 0.5 μm-1.5 μm, and the second filter pore size is in the range of 0.1 μm-0.5 μm.

7. The blood collection tube (100) according to claim 6, wherein the first filter pore size is in the range of 0.5 μm-0.8 μm, and wherein the second filter pore size is in the range of 0.2 μm-0.5 μm.

8. The blood collection tube (100) according to claim 1, wherein the outer tube wall (230) extends from the outer tube bottom (210) to the outer tube opening (220), the outer tube opening (220) includes an outer tube flange (221) extending outward from the outer tube wall (230), and the inner tube opening (320) of the inner tube (120) includes an inner tube flange (321) extending outward from the inner tube wall (330), The first inner surface (322) of the inner tube flange (321) facing the inner tube bottom (310) abuts against the second outer surface (222) of the outer tube flange (221) facing away from the outer tube bottom (210).

9. The blood collection tube (100) according to claim 8, wherein the outer tube opening (220) further comprises an outer tube opening peripheral wall (223) extending from the outer edge of the outer tube flange (221) along the first direction, and the blood collection tube (100) further comprises a tube cover (130) disposed in the outer tube opening (220), The outer wall of the tube cover (130) abuts against the outer tube opening peripheral wall (223), and the end of the tube cover (130) abuts against the first outer surface of the inner tube flange (321) facing away from the inner tube bottom (310).

10. The blood collection tube according to claim 9, wherein the tube cover (130) is made of elastic material.

11. A method (600) for preparing acellular plasma, comprising: Placing whole blood of a subject in the inner tube (120) of the blood collection tube (100) according to any one of the preceding claims; Performing a centrifugal operation on the blood collection tube (100) so that the plasma in the whole blood passes through the filter portion (340) of the inner tube (120) and enters the outer tube (110) of the blood collection tube (100); removing the inner tube (120) from the blood collection tube (100); and The plasma in the outer tube (110) is obtained.

12. The method according to claim 11, wherein the centrifugation operation is a low-speed centrifugation operation, wherein the conditions of the low-speed centrifugation operation are: centrifugal force of 1500-4500g, centrifugation time of 5-20 minutes, and centrifugation temperature of 2-8°C.

13. The method according to claim 12, wherein the conditions of the low-speed centrifugation operation are: centrifugal force of 2000-3000g, centrifugal time of 10-15 minutes, and centrifugal temperature of 2-8°C.

14. Use of the blood collection tube according to any one of claims 1 to 10 in preparing decellularized plasma.

Citation Information

Cited By

  • Blood collection tube, method for preparing cell-free plasma, and use thereof

    WO2026041100A1